Back to Search
Start Over
Neoadjuvant treatment for intermediate/high-risk HER2-positive and triple-negative breast cancers: No longer an option' but an ethical obligation
- Source :
- ESMO Open, 4 (3
- Publication Year :
- 2019
-
Abstract
- SCOPUS: ed.j<br />info:eu-repo/semantics/published
Details
- Database :
- OAIster
- Journal :
- ESMO Open, 4 (3
- Notes :
- 1 full-text file(s): application/pdf, English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1110018916
- Document Type :
- Electronic Resource